ascopubs.org

Integrating Pathologic Stage and Perioperative Circulating Tumor Cell Variations: Early Relapse Prediction Model for Resectable Non–Small Cell Lung Cancer

Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Ninety-nine patients with resectable ...
The Chosun Ilbo on MSN

Non-Smoker Lung Cancer Surge, Rycarza Effective for Brain Metastasis

According to the latest statistics from the Ministry of Data and Statistics, 21.9% of cancer-related deaths are attributed to ...
The Lancet

Progress in outcomes for patients with metastatic squamous non-small-cell lung cancer

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...
ascopubs.org

Safety, efficacy, and tumor immune microenvironment changes with neoadjuvant chemotherapy and cemiplimab with or without alirocumab in stage 1B-3A non-small cell lung cancer.

Phase 2 peri-operative study of fianlimab + cemiplimab + chemotherapy versus cemiplimab + chemotherapy in resectable early-stage non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract ...
Hosted on MSN

Everything You Need to Know About Lung Cancer

Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.
HUB

Immunotherapy plus chemotherapy before lung cancer surgery significantly improves long-term survival, analysis finds

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...